BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Bleomycin
,
rs4950928
,
SLC12A1
,
cell-cell adhesion
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
prazosin
Summary
General Info
Curated Studies
Most Correlated Studies
Livers of CD-1 mice treated with genotoxic, non-genotoxic or non-hepatocarcinogens
Hepatocyte cells of Wistar rats treated with 29 different hepatotoxic compounds
Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin.
Prazosin for nightmares in serious illness.
Prazosin administration increases the rate of recurrent urethral obstruction in cats: 388 cases.
A randomized controlled clinical trial of prazosin for alcohol use disorder in active duty soldiers:…
The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartmen…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Prazosin for ETOH or Cocaine Craving
Prazosin for Post-Concussive Headaches
Prazosin for Agitation in Alzheimer's Disease
Varenicline + Prazosin for Heavy Drinking Smokers
AScVS and/ or Prazosin for Scorpion Envenomation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ